 |
24 Diseases |  |
1 Trial |
|
1 Trial |  |
34 News |  |
- | Lantus (insulin glargine) / Sanofi
Enrollment change: Comparison Study of Insulin Glargine and NPH Insulin (clinicaltrials.gov) - Mar 10, 2020
P4, N=0, Withdrawn, Sponsor: Providence Health & Services
N=500 --> 0
- | Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia (clinicaltrials.gov) - Aug 26, 2019
P4, N=3, Terminated, Sponsor: Northwestern University
N=500 --> 0 N=50 --> 3 | Trial completion date: Dec 2020 --> Aug 2019 | Recruiting --> Terminated | Trial primary completion date: Mar 2020 --> Aug 2019; Unable to recruit sufficient number of patients
- | Novolin N (isophane insulin) / Novo Nordisk
Can u ask your doctor whether you can be managed on Novolin N, at <$30 for 10ml of U100? (Twitter) - Apr 27, 2019
- | Novolin R (recombinant human insulin) / Novo Nordisk, Novolin N (isophane insulin) / Novo Nordisk
I don’t know which insulin you use, I use Novolin R & Novolin N I get it at Walmart for $24.88 a vail. (Twitter) - Apr 20, 2019
- | New P4 trial: Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia (clinicaltrials.gov) - Apr 26, 2018
P4, N=50, Recruiting, Sponsor: Northwestern University
- | Apidra (insulin glulisine) / Sanofi
Trial completion, Enrollment change, Head-to-Head: Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes (clinicaltrials.gov) - Apr 18, 2018
P2, N=17, Completed, Sponsor: Sansum Diabetes Research Institute
N=50 --> 3 | Trial completion date: Dec 2020 --> Aug 2019 | Recruiting --> Terminated | Trial primary completion date: Mar 2020 --> Aug 2019; Unable to recruit sufficient number of patients Active, not recruiting --> Completed | N=74 --> 17
- Lantus (insulin glargine) / Sanofi
Enrollment change, Trial withdrawal: InovaDM2: The Inova Type 2 Diabetes Mellitus Study (clinicaltrials.gov) - Aug 8, 2016
P=N/A, N=0, Withdrawn, Sponsor: Inova Health Care Services
Active, not recruiting --> Completed | N=74 --> 17 N=115 --> 0 | Not yet recruiting --> Withdrawn
- Enrollment change, Trial termination, Post-transplantation: PTHG: Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia (clinicaltrials.gov) - Dec 10, 2015
P4, N=5, Terminated, Sponsor: Vancouver General Hospital
N=115 --> 0 | Not yet recruiting --> Withdrawn N=120 --> 5 | Recruiting --> Terminated; Poor enrollment
- ||| Apidra (insulin glulisine) / Sanofi
Enrollment closed, Head-to-Head: Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes (clinicaltrials.gov) - May 20, 2015
P2, N=74, Active, not recruiting, Sponsor: William Sansum Diabetes Center
N=120 --> 5 | Recruiting --> Terminated; Poor enrollment Recruiting --> Active, not recruiting
- Lantus (insulin glargine) / Sanofi
Trial initiation date, Trial primary completion date: InovaDM2: The Inova Type 2 Diabetes Mellitus Study (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=115, Not yet recruiting, Sponsor: Inova Health Care Services
Recruiting --> Active, not recruiting Initiation date: Sep 2014 --> Apr 2015 | Trial primary completion date: Aug 2015 --> Apr 2016
- Lantus (insulin glargine) / Sanofi
Clinical: InovaDM2: The Inova Type 2 Diabetes Mellitus Study (clinicaltrials.gov) - Aug 21, 2014
P=N/A, N=115, Not yet recruiting, Sponsor: Inova Health Care Services
- | Trial completion: Action to Control Cardiovascular Risk in Diabetes (ACCORD) (clinicaltrials.gov) - Feb 6, 2014
P3, N=10251, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Initiation date: Sep 2014 --> Apr 2015 | Trial primary completion date: Aug 2015 --> Apr 2016 Active, not recruiting --> Completed
- | Wosulin R (recombinant human insulin biosimilar) / Wockhardt, Wosulin N (isophane insulin biosimilar) / Wockhardt, Wosulin 30/70 (recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70%) / Wockhardt
Trial termination: Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics (clinicaltrials.gov) - Aug 20, 2013
P3, N=134, Terminated, Sponsor: Wockhardt
Active, not recruiting --> Completed Recruiting --> Terminated; Business reasons
- | Wosulin R (recombinant human insulin biosimilar) / Wockhardt, Wosulin N (isophane insulin biosimilar) / Wockhardt, Wosulin 30/70 (recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70%) / Wockhardt
Enrollment change: Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics (clinicaltrials.gov) - Aug 20, 2013
P3, N=134, Terminated, Sponsor: Wockhardt
Recruiting --> Terminated; Business reasons N=242 --> 134
- metformin / Generic mfg.
Enrollment change: MIPOD: Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes (clinicaltrials.gov) - May 21, 2013
P2, N=32, Completed, Sponsor: University of North Carolina, Chapel Hill
N=242 --> 134 N=100 --> 32
- metformin / Generic mfg.
Trial completion: MIPOD: Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes (clinicaltrials.gov) - May 21, 2013
P2, N=32, Completed, Sponsor: University of North Carolina, Chapel Hill
N=100 --> 32 Recruiting --> Completed
- | Lantus (insulin glargine) / Sanofi
New P4 trial: Comparison Study of Insulin Glargine and NPH Insulin (clinicaltrials.gov) - May 13, 2013
P4, N=500, Enrolling by invitation, Sponsor: Providence Health & Services
- ||| Apidra (insulin glulisine) / Sanofi
Trial initiation date, Head-to-Head: Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes (clinicaltrials.gov) - May 5, 2013
P2, N=74, Recruiting, Sponsor: Sansum Diabetes Research Institute
Recruiting --> Completed Initiation date: Oct 2012 --> Apr 2013
- |||| Apidra (insulin glulisine) / Sanofi
Enrollment open, Head-to-Head: Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes (clinicaltrials.gov) - May 5, 2013
P2, N=74, Recruiting, Sponsor: Sansum Diabetes Research Institute
Initiation date: Oct 2012 --> Apr 2013 Not yet recruiting --> Recruiting
- Novolin R (recombinant human insulin) / Novo Nordisk, Novolin N (isophane insulin) / Novo Nordisk
Clinical: Impact of Blood Glucose at the First Trimester of Pregnant Women With Gestational Diabetes on Maternal and Fetal Outcomes and Metabolic Disorders: a Multi-central Prospective Cohort Study (clinicaltrials.gov) - Apr 15, 2013
P=N/A, N=3, Recruiting, Sponsor: First Affiliated Hospital, Sun Yat-Sen University
- Enrollment open, Post-transplantation: PTHG: Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia (clinicaltrials.gov) - Oct 16, 2012
P4, N=120, Recruiting, Sponsor: Vancouver General Hospital
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| Apidra (insulin glulisine) / Sanofi
New P2 trial, Head-to-Head: Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes (clinicaltrials.gov) - Aug 9, 2012
P2, N=74, Recruiting, Sponsor: Sansum Diabetes Research Institute
- | New P4 trial, Post-transplantation: PTHG: Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia (clinicaltrials.gov) - Jul 22, 2012
P4, N=120, Recruiting, Sponsor: Vancouver General Hospital